Review




Structured Review

SomaLogic aptamer-based assays somalogic
Aptamer Based Assays Somalogic, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/somalogic+aptamers/bio_rxiv__2025__07__08__663798-13-2-8
Average 90 stars, based on 1 article reviews
aptamer-based assays somalogic - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

DNA Methylation Assay:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Nuclear Magnetic Resonance:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Multiplex Assay:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Real-time Polymerase Chain Reaction:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Hydrophilic Interaction Liquid Chromatography:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Liquid Chromatography with Mass Spectroscopy:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.

Gas Chromatography-Mass Spectrometry:

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: We replicated nine of these associations in 733 plasma samples from the Longenity Gene Project (LGP) that used the same Somalogic technology.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes.
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with 1H NMR deploying Chenomx.

Article Title: Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
Article Snippet: We used aptamer-based technology (SomaLogic®) to measure proteins in 1599 serum samples, 85 cerebrospinal fluid samples and 37 brain tissue samples collected from two observational longitudinal cohorts (the Oxford Parkinson’s Disease Centre and Tracking Parkinson’s) and the Parkinson’s Disease Brain Bank, respectively.

Article Title: A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Article Snippet: CLIN clinical chemistry parameters, DNA genotype data, MET DNA methylation sites, RNA RNA transcripts determined with RNA-sequencing, miRNA microRNA profiles, SOMA blood circulating proteins measured with aptamer-based technology (SomaLogic), OLINK blood circulating proteins measured using high-multiplex immunoassays (Olink), PGP glycan traits N-glycosylation, IgG IgG-glycopepdides, IgA IgA and IgG-glycopeptides BRAIN plasma lipoproteins, LD plasma lipids quantified using Lipidyzer, BM plasma lipids quantified with Biocrates p150 kit, HDF plasma metabolic traits profiled on HD4 platform (Metabolon), PM plasma metabolic traits profiled on HD2 platform (Metabolon), SM saliva metabolic traits profiled on HD2 platform (Metabolon), UM urine metabolic traits profiled on HD2 platform (Metabolon), CM urine metabolites quantified with H NMR deploying Chenomx.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: The serum proteins were profiled using the aptamer-based Somalogic technology.

Article Title: Robust Serum Proteomic Signatures of APOE2
Article Snippet: To address this knowledge gap, we previously identified a serum protein signature of e2 by correlating APOE genotypes of 224 participants of the New England Centenarian Study (NECS) with 4,137 serum proteins that we profiled using the aptamer-based Somalogic technology.



Similar Products

90
SomaLogic aptamer-based assays somalogic
Aptamer Based Assays Somalogic, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/somalogic+aptamers/bio_rxiv__2025__07__08__663798-13-2-8
Average 90 stars, based on 1 article reviews
aptamer-based assays somalogic - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SomaLogic aptamer-based somalogic
Aptamer Based Somalogic, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/somalogic+aptamers/bio_rxiv__2025__05__24__655950-10-37-38
Average 90 stars, based on 1 article reviews
aptamer-based somalogic - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SomaLogic somalogic aptamer-based platform
Somalogic Aptamer Based Platform, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/somalogic+aptamers/pm40436620-89-17-17
Average 90 stars, based on 1 article reviews
somalogic aptamer-based platform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SomaLogic aptamer-based somalogic platform of ~5000 proteins
Aptamer Based Somalogic Platform Of ~5000 Proteins, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/profiling+of++5000+proteins+using+the+somalogic+somascan+platform/10__1161_slash_jaha__124__036336-7-6-8
Average 90 stars, based on 1 article reviews
aptamer-based somalogic platform of ~5000 proteins - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SomaLogic aptamer-based somalogic platform
Aptamer Based Somalogic Platform, supplied by SomaLogic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptamer-based+somalogic/somalogic+aptamers/10__1172_slash_jci181802-38-16-17
Average 90 stars, based on 1 article reviews
aptamer-based somalogic platform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results